The Global Humanized Mouse and Rat Model Market size was valued at USD 242.3 Mn. in 2022. The Humanized Mouse and Rat Model Market revenue is growing by 6.1% from 2023 to 2029, reaching nearly USD 366.74 Mn.Humanized Mouse and Rat Model Market overview:
Humanized mouse and rat models are experimental animals that have been genetically modified or manipulated to have certain human genes, tissues, or immune systems. These models are used in biomedical research to better understand human biology, study disease mechanisms, and test potential therapies. Humanized models are particularly valuable when studying diseases that primarily affect humans or when testing treatments that have human-specific effects. The global humanized mouse and rat model market is driven by increased research in areas such as immunology, oncology, infectious diseases, and drug development. Growing emphasis on understanding human-specific diseases and treatments has escalated the demand for humanized models. These models are instrumental in developing personalized therapies personalized to individual patient genetics and disease profiles. The humanized mouse and rat model market is expected to continue growing as precision medicine and personalized therapies gain prominence. Advancements in genetic engineering techniques, such as CRISPR-Cas9, are likely to make it easier to create more sophisticated humanized models.To know about the Research Methodology :- Request Free Sample Report
Humanized Mouse and Rat Model Market Methodology:
The methodology employed in the analysis of the Humanized Mouse and Rat Model Market involves a comprehensive approach that encompasses segmentation and regional analysis. This report offers an intricate perspective on the global market for humanized mouse and rat models, considering various key factors, including the types of humanized models, their applications, industry participants, key geographical regions and countries, market share distribution, and potential growth opportunities. The report conducts an exhaustive examination of the competitive landscape within the global humanized mouse and rat model market. To achieve this, a systematic approach is undertaken, commencing with data collection and extensive market research across various segments. Different types of humanized models are meticulously scrutinized, along with an assessment of their applications. The roles and contributions of major industry players are thoroughly examined. Key regions and countries are analyzed to provide a comprehensive global perspective on the dynamics of the market. The report incorporates statistical analysis and data-driven insights to present a holistic view of the global humanized mouse and rat model market, ensuring that stakeholders make well-informed decisions based on a profound understanding of the market's intricacies.Humanized Mouse and Rat Model Market Dynamics:
Driver Rising Use of Humanized Models in Drug Discovery and Research Boosts Market Growth The growing adoption of humanized mouse and rat models in drug discovery and research has substantially boosted the expansion of the market for these models. These genetically modified models exhibit human-like traits and are pivotal in preclinical testing and drug development procedures. Humanized models provide a valuable platform for studying human-specific diseases, evaluating drug efficacy, and assessing potential toxicity, reducing the gap between preclinical and clinical trials. They offer a more accurate representation of human biology and drug responses, which is especially crucial in the development of personalized medicine and targeted therapies. Researchers and pharmaceutical companies depend on humanized models to better understand disease mechanisms and test novel treatments, ultimately expediting the drug development pipeline. As drug discovery becomes increasingly focused on precision medicine and tailored therapeutics, the demand for humanized mouse and rat models continues to surge. Their contribution to accelerating breakthroughs in healthcare and the development of more effective drugs positions them as indispensable tools in modern biomedical research, driving the growth of this market. Restrain High cost of custom humanized Models Restrains the Market Growth The high cost of custom humanized mouse and rat models serves as a major impediment to the growth of the humanized mouse and rat model market. The development of custom models involves intricate genetic engineering, demanding technical expertise, and access to advanced laboratory facilities. This results in significant upfront costs and extended timelines, with researchers investing substantial resources in planning, generating, and validating these models. Ongoing maintenance of humanized colonies, adherence to ethical and regulatory guidelines, and the scarcity of specialized expertise further contribute to the cost burden. Limited funding for research projects also helps researchers opt for more cost-effective off-the-shelf models instead. To foster growth in the market, efforts to reduce costs, enhance efficiency, and encourage collaborative research initiatives are essential to make custom humanized models more accessible to a wider range of researchers and institutions. Opportunity Advancements in Personalized Medicine create lucrative growth opportunities for the market growth Advancements in personalized medicine are revolutionizing healthcare by tailoring medical approaches to individual patients. This transformative paradigm takes into account a person's unique genetic, environmental, and lifestyle factors to make informed medical decisions and interventions. One key component is genomic medicine, where genetic information is harnessed to identify disease predispositions and predict responses to treatments. This empowers healthcare providers to create highly customized care plans, offering early disease detection and precision treatments. Personalized medicine also fosters the development of targeted therapies, especially in fields such as oncology and rare diseases. Understanding a patient's molecular disease characteristics, treatment is more effective and less harmful. Pharmacogenomics further enhances the approach, considering an individual's genetic variations that impact drug metabolism, and optimizing medication selection and dosage for better outcomes. Personalized medicine promotes proactive healthcare by predicting disease risks and allowing preventive measures. Patients actively participate in their care decisions, leading to a patient-centric approach. In the field of research, clinical trials are increasingly adopting a personalized methodology. The personalized medicine method divides people into groups according to their genetic profiles, those who respond well to experimental drugs and those who won't. Diverse data sources, such as genetics, electronic health records, and wearable tech, are smoothly combined in personalized medicine using advanced data analytics and artificial intelligence. These innovations carry the potential to significantly transform healthcare, leading to enhanced treatment results, decreased side effects, and an elevated standard of patient care. Ultimately, this shift will drive a healthcare system that is more efficient and centered around the patient.Total Global Market For Personalized Medicine From 2018 To 2022 (In Billion U.S. Dollars)
Humanized Mouse and Rat Model Market Segment Analysis:
Based on Application: The immunology segment dominated the application segment of the Humanized Mouse and Rat Model Market in the year 2022. Due to the significance of these models in studying immune responses and infectious diseases. However, the oncology segment is anticipated to experience the most significant growth. This growth is primarily driven by the increasing prevalence of cancer and a surge in cancer research activities. Researchers are innovating to develop humanized mouse models that are specifically tailored to mimic the complex interactions and characteristics of various cancers, facilitating more accurate and targeted cancer research. These models play a crucial role in testing novel therapies, understanding tumour biology, and evaluating treatment efficacy. The oncology segment is expected to witness substantial growth in the market as the demand for personalized and precise cancer research models continues to rise.Humanized Mouse and Rat Model Market Based on Application In the year 2022 in (%)
Regional Insight:
North America dominated the Humanized Mouse and Rat Model Market in the year 2022. The region's strong academic and industrial presence has driven high demand for mouse models of human disease, particularly in preclinical drug development, immunology, and infectious disease research. North America has been at the forefront of technological advancements and innovation in genetic engineering and biomedical research techniques. This has enabled the development of sophisticated humanized models that closely mimic human physiology, attracting researchers and organizations from around the world. The presence of research funding and investments in the life sciences sector has spurred the growth of this market. Entities such as the National Institutes of Health (NIH) and various government agencies, in addition to private funding sources, have provided crucial backing for research endeavors involving humanized models. A firmly established regulatory framework and ethical standards for utilizing animal models in research have fostered a favorable environment for market growth. Competitive Landscape The Humanized Mouse and Rat Model Market is characterized by a multitude of providers, including small, medium, and large companies offering both models and testing services. Many of these businesses command significant market shares within their respective regions. Taconic Biosciences, Inc. stands out as a key player, offering a diverse range of innovative solutions that find global use among researchers and professionals. Charles River Laboratories boasts a vast network of over 20 breeding facilities worldwide, dedicated to generating rat and mouse animal models. Major industry players have also pursued strategic initiatives to expand their market presence. For instance, in February 2020, Taconic Biosciences extended its operations to produce mouse models with humanized immune systems in Europe. This move augmented the company's manufacturing capacity and broadened its customer base within the European region, underscoring the competitive nature of the industry.Humanized Mouse and Rat Model Market Scope Table : Inquire Before Buying
Global Humanized Mouse and Rat Model Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 242.3 Mn. Forecast Period 2023 to 2029 CAGR: 6.1% Market Size in 2029: US $ 366.74 Mn. Segments Covered: by Type Genetic Models Cell-Based Model Rat Model by Application Oncology Immunology and Infectious Diseases Neuroscience Haematopoiesis Toxicology Others by End User Pharmaceutical and Biotechnology Companies Contract Research Organisations Academic and Research Institutions Humanized Mouse and Rat Model Market by Region
North America (United States, Canada, and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan, and the Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria, and the Rest of ME&A) South America (Brazil, Argentina Rest of South America)Humanized Mouse and Rat Model Market Key Players
1. The Jackson Laboratory 2. Charles River Laboratories 3. Taconic Biosciences 4. Horizon Discovery 5. Crown Bioscience 6. InVivoMAb 7. Trans Genic Inc. 8. Genoway 9. Hera Biolabs 10. Janvier Labs 11. Ingenious Targeting Laboratory 12. Pharmaron 13. Oncodesign 14. genOway S.A. 15. Yecuris Corporation Frequently Asked Questions: 1] What segments are covered in the Global Market report? Ans. The segments covered in the Market report are based on Type, Application, End User, and Regions. 2] Which region is expected to hold the highest share in the Global Model Market? Ans. The North American region is expected to hold the highest share of the Humanized Mouse and Rat Model Market. 3] What was the market size of the Global Market by 2022? Ans. The market size of the Humanized Mouse and Rat Model Market by 2022 is expected to reach US$ 242.3 Mn. 4] What is the forecast period for the Global Humanized Mouse and Rat Model Market? Ans. The forecast period for the Humanized Mouse and Rat Model Market is 2023-2029. 5] What is the market size of the Global Humanized Mouse and Rat Model Market in 2029? Ans. The market size of the Humanized Mouse and Rat Model Market in 2029 is valued at US$ 366.74 Mn.
1. Humanized Mouse and Rat Model Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Humanized Mouse and Rat Model Market: Dynamics 2.1. Humanized Mouse and Rat Model Market Trends by Region 2.1.1. North America Humanized Mouse and Rat Model Market Trends 2.1.2. Europe Humanized Mouse and Rat Model Market Trends 2.1.3. Asia Pacific Humanized Mouse and Rat Model Market Trends 2.1.4. Middle East and Africa Humanized Mouse and Rat Model Market Trends 2.1.5. South America Humanized Mouse and Rat Model Market Trends 2.2. Humanized Mouse and Rat Model Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Humanized Mouse and Rat Model Market Drivers 2.2.1.2. North America Humanized Mouse and Rat Model Market Restraints 2.2.1.3. North America Humanized Mouse and Rat Model Market Opportunities 2.2.1.4. North America Humanized Mouse and Rat Model Market Challenges 2.2.2. Europe 2.2.2.1. Europe Humanized Mouse and Rat Model Market Drivers 2.2.2.2. Europe Humanized Mouse and Rat Model Market Restraints 2.2.2.3. Europe Humanized Mouse and Rat Model Market Opportunities 2.2.2.4. Europe Humanized Mouse and Rat Model Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Humanized Mouse and Rat Model Market Drivers 2.2.3.2. Asia Pacific Humanized Mouse and Rat Model Market Restraints 2.2.3.3. Asia Pacific Humanized Mouse and Rat Model Market Opportunities 2.2.3.4. Asia Pacific Humanized Mouse and Rat Model Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Humanized Mouse and Rat Model Market Drivers 2.2.4.2. Middle East and Africa Humanized Mouse and Rat Model Market Restraints 2.2.4.3. Middle East and Africa Humanized Mouse and Rat Model Market Opportunities 2.2.4.4. Middle East and Africa Humanized Mouse and Rat Model Market Challenges 2.2.5. South America 2.2.5.1. South America Humanized Mouse and Rat Model Market Drivers 2.2.5.2. South America Humanized Mouse and Rat Model Market Restraints 2.2.5.3. South America Humanized Mouse and Rat Model Market Opportunities 2.2.5.4. South America Humanized Mouse and Rat Model Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Value Chain Analysis 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Humanized Mouse and Rat Model Clinical Trial Analysis for Humanized Mouse and Rat Model 2.8. Key Opinion Leader Analysis For Humanized Mouse and Rat Model Industry 2.9. Analysis of Government Schemes and Initiatives For Humanized Mouse and Rat Model Industry 2.10. The Global Pandemic Impact on the Humanized Mouse and Rat Model Market 2.11. Humanized Mouse and Rat Model Price Trend Analysis (2021-22) 3. Humanized Mouse and Rat Model Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2022-2029) 3.1. Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 3.1.1. Genetic Models 3.1.2. Cell-Based Model 3.1.3. Rat Model 3.2. Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 3.2.1. Oncology 3.2.2. Immunology and Infectious Diseases 3.2.3. Neuroscience 3.2.4. Haematopoiesis 3.2.5. Toxicology 3.2.6. Others 3.3. Humanized Mouse and Rat Model Market Size and Forecast, by End User (2022-2029) 3.3.1. Pharmaceutical and Biotechnology Companies 3.3.2. Contract Research Organisations 3.3.3. Academic and Research Institutions 3.4. Humanized Mouse and Rat Model Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Humanized Mouse and Rat Model Market Size and Forecast by Segmentation (by Value in USD Million) (2022-2029) 4.1. North America Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 4.1.1. Genetic Models 4.1.2. Cell-Based Model 4.1.3. Rat Model 4.2. North America Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 4.2.1. Oncology 4.2.2. Immunology and Infectious Diseases 4.2.3. Neuroscience 4.2.4. Haematopoiesis 4.2.5. Toxicology 4.2.6. Others 4.3. North America Humanized Mouse and Rat Model Market Size and Forecast, by End User (2022-2029) 4.3.1. Pharmaceutical and Biotechnology Companies 4.3.2. Contract Research Organisations 4.3.3. Academic and Research Institutions 4.4. North America Humanized Mouse and Rat Model Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 4.4.1.1.1. Genetic Models 4.4.1.1.2. Cell-Based Model 4.4.1.1.3. Rat Model 4.4.1.2. United States Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 4.4.1.2.1. Oncology 4.4.1.2.2. Immunology and Infectious Diseases 4.4.1.2.3. Neuroscience 4.4.1.2.4. Haematopoiesis 4.4.1.2.5. Toxicology 4.4.1.2.6. Others 4.4.1.3. United States Humanized Mouse and Rat Model Market Size and Forecast, by End User (2022-2029) 4.4.1.3.1. Pharmaceutical and Biotechnology Companies 4.4.1.3.2. Contract Research Organisations 4.4.1.3.3. Academic and Research Institutions 4.4.2. Canada 4.4.2.1. Canada Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 4.4.2.1.1. Genetic Models 4.4.2.1.2. Cell-Based Model 4.4.2.1.3. Rat Model 4.4.2.2. Canada Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 4.4.2.2.1. Oncology 4.4.2.2.2. Immunology and Infectious Diseases 4.4.2.2.3. Neuroscience 4.4.2.2.4. Haematopoiesis 4.4.2.2.5. Toxicology 4.4.2.2.6. Others 4.4.2.3. Canada Humanized Mouse and Rat Model Market Size and Forecast, by End User (2022-2029) 4.4.2.3.1. Pharmaceutical and Biotechnology Companies 4.4.2.3.2. Contract Research Organisations 4.4.2.3.3. Academic and Research Institutions 4.4.3. Mexico 4.4.3.1. Mexico Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 4.4.3.1.1. Genetic Models 4.4.3.1.2. Cell-Based Model 4.4.3.1.3. Rat Model 4.4.3.2. Mexico Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 4.4.3.2.1. Oncology 4.4.3.2.2. Immunology and Infectious Diseases 4.4.3.2.3. Neuroscience 4.4.3.2.4. Haematopoiesis 4.4.3.2.5. Toxicology 4.4.3.2.6. Others 4.4.3.3. Mexico Humanized Mouse and Rat Model Market Size and Forecast, by End User (2022-2029) 4.4.3.3.1. Pharmaceutical and Biotechnology Companies 4.4.3.3.2. Contract Research Organisations 4.4.3.3.3. Academic and Research Institutions 5. Europe Humanized Mouse and Rat Model Market Size and Forecast by Segmentation (by Value in USD Million) (2022-2029) 5.1. Europe Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 5.2. Europe Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 5.3. Europe Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 5.4. Europe Humanized Mouse and Rat Model Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 5.4.1.2. United Kingdom Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 5.4.1.3. United Kingdom Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 5.4.2. France 5.4.2.1. France Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 5.4.2.2. France Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 5.4.2.3. France Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 5.4.3. Germany 5.4.3.1. Germany Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 5.4.3.2. Germany Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 5.4.3.3. Germany Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 5.4.4. Italy 5.4.4.1. Italy Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 5.4.4.2. Italy Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 5.4.4.3. Italy Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 5.4.5. Spain 5.4.5.1. Spain Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 5.4.5.2. Spain Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 5.4.5.3. Spain Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 5.4.6.2. Sweden Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 5.4.6.3. Sweden Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 5.4.7. Austria 5.4.7.1. Austria Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 5.4.7.2. Austria Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 5.4.7.3. Austria Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 5.4.8.2. Rest of Europe Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 5.4.8.3. Rest of Europe Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 6. Asia Pacific Humanized Mouse and Rat Model Market Size and Forecast by Segmentation for Demand and Supply Side (by Value in USD Million) (2022-2029) 6.1. Asia Pacific Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 6.2. Asia Pacific Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 6.3. Asia Pacific Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 6.4. Asia Pacific Humanized Mouse and Rat Model Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 6.4.1.2. China Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 6.4.1.3. China Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 6.4.2.2. S Korea Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 6.4.2.3. S Korea Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 6.4.3. Japan 6.4.3.1. Japan Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 6.4.3.2. Japan Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 6.4.3.3. Japan Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 6.4.4. India 6.4.4.1. India Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 6.4.4.2. India Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 6.4.4.3. India Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 6.4.5. Australia 6.4.5.1. Australia Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 6.4.5.2. Australia Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 6.4.5.3. Australia Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 6.4.6.2. Indonesia Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 6.4.6.3. Indonesia Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 6.4.7.2. Malaysia Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 6.4.7.3. Malaysia Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 6.4.8.2. Vietnam Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 6.4.8.3. Vietnam Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 6.4.9.2. Taiwan Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 6.4.9.3. Taiwan Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 6.4.10.2. Rest of Asia Pacific Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 6.4.10.3. Rest of Asia Pacific Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 7. Middle East and Africa Humanized Mouse and Rat Model Market Size and Forecast by Segmentation for Demand and Supply Side (by Value in USD Million) (2022-2029 7.1. Middle East and Africa Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 7.2. Middle East and Africa Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 7.3. Middle East and Africa Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 7.4. Middle East and Africa Humanized Mouse and Rat Model Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 7.4.1.2. South Africa Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 7.4.1.3. South Africa Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 7.4.2. GCC 7.4.2.1. GCC Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 7.4.2.2. GCC Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 7.4.2.3. GCC Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 7.4.3.2. Nigeria Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 7.4.3.3. Nigeria Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 7.4.4.2. Rest of ME&A Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 7.4.4.3. Rest of ME&A Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 8. South America Humanized Mouse and Rat Model Market Size and Forecast by Segmentation for Demand and Supply Side (by Value in USD Million) (2022-2029 8.1. South America Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 8.2. South America Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 8.3. South America Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 8.4. South America Humanized Mouse and Rat Model Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 8.4.1.2. Brazil Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 8.4.1.3. Brazil Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 8.4.2.2. Argentina Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 8.4.2.3. Argentina Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Humanized Mouse and Rat Model Market Size and Forecast, by Type (2022-2029) 8.4.3.2. Rest Of South America Humanized Mouse and Rat Model Market Size and Forecast, by Application (2022-2029) 8.4.3.3. Rest Of South America Humanized Mouse and Rat Model Market Size and Forecast, by End User(2022-2029) 9. Global Humanized Mouse and Rat Model Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Product Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Humanized Mouse and Rat Model Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Allogene Therapeutics 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Recent Developments 10.2. Bluebird Bio - United States 10.3. Mustang Bio - United States 10.4. NantKwest - United States 10.5. Nkarta Therapeutics - United States 10.6. Precision BioSciences - United States 10.7. Sangamo Therapeutics - United States 10.8. TCR2 Therapeutics - United States 10.9. Unum Therapeutics - United States 10.10. WindMIL Therapeutics - United States 10.11. Gilead Sciences - United States 10.12. Iovance Biotherapeutics - United States 10.13. CRISPR Therapeutics - Switzerland 10.14. Gamida Cell - Israel 10.15. Iovance Biotherapeutics - United States 10.16. Kiadis Pharma - Netherlands 10.17. MaxCyte - United Kingdom 10.18. Adaptimmune Therapeutics - United Kingdom 10.19. Cellectis – France 10.20. Celyad – Belgium 10.21. Novartis - Switzerland 10.22. TC BioPharm - United Kingdom 10.23. Tessa Therapeutics – Singapore 10.24. Mesoblast – Australia 10.25. CARsgen Therapeutics – China 11. Key Findings 12. Industry Recommendations 13. Humanized Mouse and Rat Model Market: Research Methodology